Oncocyte Corp Quarterly Cost of Revenue in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Oncocyte Corp quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q2 2024.
  • Oncocyte Corp Cost of Revenue for the quarter ending June 30, 2024 was $32K, a 81.1% decline year-over-year.
  • Oncocyte Corp Cost of Revenue for the twelve months ending June 30, 2024 was $852K, a 17% decline year-over-year.
  • Oncocyte Corp annual Cost of Revenue for 2023 was $1M, a 13.9% increase from 2022.
  • Oncocyte Corp annual Cost of Revenue for 2022 was $880K, a 26.3% increase from 2021.
  • Oncocyte Corp annual Cost of Revenue for 2021 was $697K, a 62.4% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $852K $32K -$137K -81.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $989K $252K -$13K -4.91% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1M $409K +$131K +47.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $871K $159K -$155K -49.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.03M $169K -$14K -7.65% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.04M $265K +$160K +152% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $880K $278K -$1.94M -87.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $2.82M $314K -$546K -63.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.37M $183K -$1.17M -86.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.54M $105K -$633K -85.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.17M $2.22M +$1.5M +210% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $3.66M $860K +$259K +43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.41M $1.35M +$985K +270% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.42M $738K +$565K +327% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.86M $716K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $601K Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 $365K Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 $173K Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.